Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geologica Closes Financing And Property Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(43)
•••
Comment by Breakthorough1on Nov 22, 2019 3:50pm
125 Views
Post# 30383746

RE:RE:RE:RE:RE:RE:From the abstract (june 27th)

RE:RE:RE:RE:RE:RE:From the abstract (june 27th)From Nov 8 call again (let's cross fingers...): "I've said in -- we said in the update today that we had 17 patients enrolled as of today. But we know we are expecting that we'll complete the enrollment of the 25 patients before the end of the year. And that in the first 6 months of next year, we should be able to report the top line data on this trial."
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities